New technique utilizes immune cell-mediated nanoparticles for Melanoma targeting and drug delivery
Researchers at Penn State Materials Research Institute (State College, PA., USA) have combined two approaches to create a smart, targeted system to attack cancers of specific types.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.